Clinical significance of cancerous inhibitor of protein phosphatase 2A in human cancers-Reference-Cited by-同舟云学术

Clinical significance of cancerous inhibitor of protein phosphatase 2A in human cancers

Published:2015-01-28 Issue:3 Volume:138 Page:525-532
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Khanna Anchit¹,Pimanda John E.¹²

Affiliation:

1. Lowy Cancer Research Centre and Prince of Wales Clinical School, University of New South Wales (UNSW) Medicine Department; Sydney New South Wales 2052 Australia

2. Department of Haematology; the Prince of Wales Hospital; Randwick New South Wales Australia

Funder

National Health and Research Medical Council (NH&MRC)-Peter-Doherty Research Fellow

National Health and Research Medical Council (NH&MRC), Australia

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference80 articles.

1. Further studies on site phosphorylated in phosphorylase B to a reaction;Nolan;Biochemistry,1964

2. Phosphatases: the new brakes for cancer development?;Zhang;Enzyme Res

3. Regulation of cell adhesion by PP2A and SV40 small tumor antigen: an important link to cell transformation;Sontag;Cell Mol Life Sci,2006

4. Involvement of PP2A in viral and cellular transformation;Arroyo;Oncogene,2005

5. Identification of PP2A complexes and pathways involved in cell transformation;Sablina;Cancer Res,2010

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Roles of B56 Phosphorylation and Binding Motif in PP2A-B56 Holoenzyme Biological Function;International Journal of Molecular Sciences;2024-03-10

2. CIP2A induces PKM2 tetramer formation and oxidative phosphorylation in non-small cell lung cancer;Cell Discovery;2024-02-06

3. CIP2A coordinates phosphosignaling, mitosis, and the DNA damage response;Trends in Cancer;2024-01

4. TIPRL1 and its ATM-dependent phosphorylation promote radiotherapy resistance in head and neck cancer;Cellular Oncology;2023-11-16

5. Exploring the composition of protein-ligand binding sites for cancerous inhibitor of PP2A (CIP2A) by inhibitor guided binding analysis: paving a new way for the Discovery of drug candidates against triple negative breast cancer (TNBC);Journal of Receptors and Signal Transduction;2023-11-02